JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells

被引:69
作者
Arguni, Eggi
Arima, Masafumi
Tsuruoka, Nobuhide
Sakamoto, Akemi
Hatano, Masahiko
Tokuhisa, Takeshi
机构
[1] Chiba Univ, Grad Sch Med, Dept Dev Genet, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Biomed Res Ctr, Chuo Ku, Chiba 2608670, Japan
关键词
cytokines; gene regulation; memory; transcription factors;
D O I
10.1093/intimm/dxl041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Bcl6 proto-oncogene, which encodes a transcriptional repressor, is ubiquitously expressed and predominantly in germinal center (GC) B cells. Although the promoter region of the human Bcl6 gene has been reported, enhancer molecules for its high expression in GC B cells were largely unknown. Here we show that transcriptional start sites of the murine Bcl6 gene were different from the reported human one. DNA sequence around the new promoter region is highly conserved between mice and humans and has no canonical TATA or CCAAT box. Two AP-1-binding elements in the promoter region were the major enhancer elements in GC-derived B lymphoma cells, and JunD/AP-1 was detected in GC B cells. In addition, we identified the silencer region with three Bcl6-binding elements around the start site. Bcl6 bound to the silencer elements and its over-expression repressed the promoter activity through the elements. Activated STAT factors (STATs), especially activated STAT3, also bound to the silencer elements in GC B cells and competed with Bcl6 for the binding, suggesting that JunD/AP-1 and activated STATs drive high Bcl6 expression in GC B cells. Since stimulation of splenic B cells with IL-4 or IL-21 induced high Bcl6 expression with induction of junD and activation of STATs, these cytokines may be inducers for its high expression in GC B cells. However, IL-21 but not IL-4 stimulation activated STAT3 in splenic B cells. Thus, IL-21 may be a major inducer for high Bcl6 expression in GC B cells.
引用
收藏
页码:1079 / 1089
页数:11
相关论文
共 48 条
  • [1] A putative silencer element in the IL-5 gene recognized by Bcl6
    Arima, M
    Toyama, H
    Ichii, H
    Kojima, S
    Okada, S
    Hatano, M
    Cheng, G
    Kubo, M
    Fukuda, T
    Tokuhisa, T
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (02) : 829 - 836
  • [2] Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production
    Breitfeld, D
    Ohl, L
    Kremmer, E
    Ellwart, J
    Sallusto, F
    Lipp, M
    Förster, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (11) : 1545 - 1551
  • [3] BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS
    CATTORETTI, G
    CHANG, CC
    CECHOVA, K
    ZHANG, JD
    YE, BH
    FALINI, B
    LOUIE, DC
    OFFIT, K
    CHAGANTI, RSK
    DALLAFAVERA, R
    [J]. BLOOD, 1995, 86 (01) : 45 - 53
  • [4] T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells
    Chtanova, T
    Tangye, SG
    Newton, R
    Frank, N
    Hodge, MR
    Rolph, MS
    Mackay, CR
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (01) : 68 - 78
  • [5] Control of inflammation, cytokine expression, and germinal center formation by BCL-6
    Dent, AL
    Shaffer, AL
    Yu, X
    Allman, D
    Staudt, LM
    [J]. SCIENCE, 1997, 276 (5312) : 589 - 592
  • [6] DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495
  • [7] Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein
    Dhordain, P
    Albagli, O
    Lin, RJ
    Ansieau, S
    Quief, S
    Leutz, A
    Kerckaert, JP
    Evans, RM
    Leprince, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10762 - 10767
  • [8] Disruption of the Bcl6 gene results in an impaired germinal center formation
    Fukuda, T
    Yoshida, T
    Okada, S
    Hatano, M
    Miki, T
    Ishibashi, K
    Okabe, S
    Koseki, H
    Hirosawa, S
    Taniguchi, M
    Miyasaka, N
    Tokuhisa, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (03) : 439 - 448
  • [9] FUKUDA T, 1995, ONCOGENE, V11, P1657
  • [10] Gupta S, 1999, J IMMUNOL, V163, P3834